Modification of mammalian reoviruses for use as oncolytic agents (Q28264900)

ORCID Public Data File 2021

author name string

Diana J M Van Den Wollenberg

0 references

Sanne K Van Den Hengel

0 references

Iris J C Dautzenberg

0 references

Onno Kranenburg

Expert Opinion on Biological Therapy

0 references

language of work or name

English

0 references

publication date

December 2009

0 references

published in

0 references

volume

0 references

issue

0 references

page(s)

1509-20

0 references

cites work

Junction adhesion molecule is a receptor for reovirus

1 reference

https://api.crossref.org/works/10.1517/14712590903307370

How Viruses Enter Animal Cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712590903307370

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712590903307370

Discovery of mammalian genes that participate in virus infection

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712590903307370

Mutations in the IGF-II pathway that confer resistance to lytic reovirus infection

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712590903307370

Reverse genetics system for introduction of site-specific mutations into the double-stranded RNA genome of infectious rotavirus

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712590903307370

Crystal structure of reovirus attachment protein sigma1 reveals evolutionary relationship to adenovirus fiber

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712590903307370

Crystal structure of human junctional adhesion molecule 1: Implications for reovirus binding

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712590903307370

Structure of Reovirus σ1 in Complex with Its Receptor Junctional Adhesion Molecule-A

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712590903307370

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712590903307370

Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712590903307370

Stem cell collection and gene transfer in Fanconi anemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Oncolytic viruses in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Reovirus activates human dendritic cells to promote innate antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Tumor infection by oncolytic reovirus primes adaptive antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Immune-mediated antitumor activity of reovirus is required for therapy and is independent of direct viral oncolysis and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Clinical update: rotavirus gastroenteritis and its prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Identification of carbohydrate-binding domains in the attachment proteins of type 1 and type 3 reoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Junctional adhesion molecule a serves as a receptor for prototype and field-isolate strains of mammalian reovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Peptides released from reovirus outer capsid form membrane pores that recruit virus particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Features of the mammalian orthoreovirus 3 Dearing l1 single-stranded RNA that direct packaging and serotype restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Localizing the reovirus packaging signals using an engineered m1 and s2 ssRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Identification of the 5' sequences required for incorporation of an engineered ssRNA into the Reovirus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Reovirus apoptosis and virulence are regulated by host cell membrane penetration efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Effect of Reovirus Infection on Pulmonary Tumor Response to Urethan in Strain A Mice2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Reovirus as a novel oncolytic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Not all viruses are bad guys: the case for reovirus in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Uncoating reo: uncovering the steps critical for oncolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Reovirus infection of cancer cells is not due to activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Proteolytic disassembly is a critical determinant for reovirus oncolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Acquired resistance to reoviral oncolysis in Ras-transformed fibrosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

The use of monoreassortants and reverse genetics to map reovirus lysis of a ras-transformed cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Reovirus: viral therapy for cancer 'as nature intended'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Reovirus-based therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

A strategy for genetic modification of the spike-encoding segment of human reovirus T3D for reovirus targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Oncolytic reovirus effectively targets breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Junctional adhesion molecule A [corrected] expression in human endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

JAM-A expression positively correlates with poor prognosis in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Characterization of the thermosensitive ts453 reovirus mutant: increased dsRNA binding of sigma 3 protein correlates with interferon resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Correlation between interferon sensitivity of reovirus isolates and ability to discriminate between normal and Ras-transformed cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Reovirus RNA is infectious

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Construction and characterization of a reovirus double temperature-sensitive mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Reovirus reverse genetics: Incorporation of the CAT gene into the reovirus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Recovery of infectious bluetongue virus from RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

A plasmid-based reverse genetics system for animal double-stranded RNA viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Incorporation of epitope-tagged viral sigma3 proteins to reovirus virions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Engineering targeted viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Matrix metalloproteinases-1 and -8 improve the distribution and efficacy of an oncolytic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Taming the Trojan horse: optimizing dynamic carrier cell/oncolytic virus systems for cancer biotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

The biology of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Stem cell concepts renew cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Characteristics of reovirus-mediated chemoimmunotherapy of murine L1210 leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Structural evidence for common functions and ancestry of the reovirus and adenovirus attachment proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Adenovirus receptors: implications for tropism, treatment and targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Immunosuppression promotes reovirus therapy of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Morbidity in immunosuppressed (SCID/NOD) mice treated with reovirus (dearing 3) as an anti-cancer biotherapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Gene-specific inhibition of reovirus replication by RNA interference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903307370

10.1517/14712590903307370

21 January 2018

Identifiers

DOI

0 references

Fatcat ID

release_ijcnupkfpzdudilks76sar5ssi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ijcnupkfpzdudilks76sar5ssi